Michael Cloonan
2018
In 2018, Michael Cloonan earned a total compensation of $4.2M as Chief Business Officer at Sage Therapeutics, a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,276 |
|---|---|
| Option Awards | $3,506,001 |
| Salary | $450,626 |
| Other | $8,982 |
| Total | $4,163,885 |
Cloonan received $3.5M in option awards, accounting for 84% of the total pay in 2018.
Cloonan also received $198.3K in non-equity incentive plan, $450.6K in salary and $9K in other compensation.
Rankings
In 2018, Michael Cloonan's compensation ranked 2,639th out of 14,244 executives tracked by ExecPay. In other words, Cloonan earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,639 out of 14,244 | 82nd |
Division Manufacturing | 978 out of 5,759 | 83rd |
Major group Chemicals And Allied Products | 334 out of 2,122 | 84th |
Industry group Drugs | 272 out of 1,811 | 85th |
Industry Pharmaceutical Preparations | 212 out of 1,385 | 85th |
Pay ratio
| Michael Cloonan's Pay | $4,163,885 |
|---|---|
| Median Employee's Pay | $589,166 |
| Pay Ratio | to 1 |
In 2018, the annual total compensation of Michael Cloonan was $4,163,885.
The annual total compensation of the median employee at Sage Therapeutics was $589,166.
The ratio of Michael Cloonan's pay to the pay of median employee was therefore to one.
Source: SEC filing on April 29, 2020.
Cloonan's colleagues
We found five more compensation records of executives who worked with Michael Cloonan at Sage Therapeutics in 2018.